Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.4757
-0.0433 (-8.34%)
At close: Sep 21, 2026, 4:00 PM EDT
0.4741
-0.0016 (-0.34%)
After-hours: Sep 21, 2026, 6:47 PM EDT
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,445,535
Market Cap
1.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2021 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Virax Biolabs Group | 26 |
| Curis | 24 |
| Tessera Defense and Homeland Security | 20 |
| Decoy Therapeutics | 11 |
| Artelo Biosciences | 7 |
BBLG News
- 13 days ago - Bone Biologics Expands Trial Sites - GlobeNewsWire
- 18 days ago - Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 5 weeks ago - Bone Biologics announces extended shelf life for rhNELL-1 protein - TheFly
- 5 weeks ago - Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1 - GlobeNewsWire
- 2 months ago - Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities - GlobeNewsWire
- 2 months ago - Bone Biologics files to sell 6.46M shares of common stock for holders - TheFly
- 2 months ago - Bone Biologics prices $9.0M offering at $1.42 per share. - TheFly
- 2 months ago - Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire